MicroRNA Dysregulation in Cystic Fibrosis

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Mckiernan, Paul J ^a   Greene, Catherine M ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE ION; MICRORNA; SMALL UNTRANSLATED RNA; CFTR PROTEIN, HUMAN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; TOLL LIKE RECEPTOR;

CYSTIC FIBROSIS; ENDOPLASMIC RETICULUM STRESS; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; ION CONDUCTANCE; LUNG DISEASE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PNEUMONIA; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; REVIEW; RNA PROCESSING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PHYSIOLOGY;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; MICRORNAS; TOLL-LIKE RECEPTORS;

EID: 84936797528     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/529642     Document Type: Review

References (83)

1. T. M. Rana, "Illuminating the silence: understanding the structure and function of smallRNAs" Nature ReviewsMolecular Cell Biology, vol. 8, no. 1, pp. 23-36, 2007.
2. R. C. Lee, R. L. Feinbaum, and V. Ambros, "The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14" Cell, vol. 75, no. 5, pp. 843-854, 1993.
3. S. Griffiths-Jones, "The microRNA registry" Nucleic Acids Research, vol. 32, pp. D109-D111, 2004.
4. Y. Lee, C. Ahn, J. Han et al., "The nuclear RNase III Drosha initiates microRNA processing" Nature, vol. 425, no. 6956, pp. 415-419, 2003.
5. E. Lund, S. Guttinger, A. Calado, J. E. Dahlberg, and U. Kutay, "Nuclear export ofMicroRNA precursors" Science, vol. 303, no. 5654, pp. 95-98, 2004.
6. K. H. Kok, M.-H. J. Ng, Y.-P. Ching, and D.-Y. Jin, "Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA" Journal of Biological Chemistry, vol. 282, no. 24, pp. 17649-17657, 2007.
7. L. Peters and G. Meister, "Argonaute proteins:mediators ofRNA silencing" Molecular Cell, vol. 26, no. 5, pp. 611-623, 2007.
8. S. M. Hammond, S. Boettcher, A. A. Caudy, R. Kobayashi, and G. J. Hannon, "Argonaute2, a link between genetic and biochemical analyses of RNAi" Science, vol. 293, no. 5532, pp. 1146-1150, 2001.
9. R. Sessa and A. Hata, "Role of microRNAs in lung development and pulmonary diseases" Pulmonary Circulation, vol. 3, no. 2, pp. 315-328, 2013.
10. I. K. Oglesby, N. G. McElvaney, and C.M. Greene, "MicroRNAs in inflammatory lung disease-master regulators or target practice?" Respiratory Research, vol. 11, no. 1, article 148, 2010.
11. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function" Cell, vol. 116, no. 2, pp. 281-297, 2004.
12. J. R. Lytle, T. A. Yario, and J. A. Steitz, "Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5 UTR as in the 3 UTR" Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 23, pp. 9667-9672, 2007.
13. J. Hausser, A. P. Syed, B. Bilen, and M. Zavolan, "Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation" Genome Research, vol. 23, no. 4, pp. 604-615, 2013.
14. S.M. Peterson, J. A. Thompson, M. L. Ufkin, P. Sathyanarayana, L. Liaw, and C. B. Congdon, "Common features of microRNA target prediction tools" Frontiers in Genetics, vol. 5, article 23, 2014.
15. R. M. O'Connell, D. S. Rao, A. A. Chaudhuri, andD. Baltimore, "Physiological and pathological roles for microRNAs in the immune system" Nature Reviews Immunology, vol. 10, no. 2, pp. 111-122, 2010.
16. R. Booton and M. A. Lindsay, "Emerging role of MicroRNAs and long noncoding RNAs in respiratory disease" Chest, vol. 146, no. 1, pp. 193-204, 2014.
17. K. Sun and E. C. Lai, "Adult-specific functions of animal micro-RNAs" Nature ReviewsGenetics, vol. 14, no. 8, pp. 535-548, 2013.
18. K. S. Harris, Z. Zhang, M. T. McManus, B. D. Harfe, and X. Sun, "Dicer function is essential for lung epitheliummorphogenesis" Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2208-2213, 2006.
19. A. E. Williams, M. M. Perry, S. A. Moschos, and M. A. Lindsay, "microRNA expression in the aging mouse lung" BMC Genomics, vol. 8, article 172, 2007.
20. C. Z. Chen, L. Li, H. F. Lodish, and D. P. Bartel, "MicroRNAs modulate hematopoietic lineage differentiation" Science, vol. 303, no. 5654, pp. 83-86, 2004.
21. T. Hassan, P. J. McKiernan, N. G. McElvaney, S. A. Cryan, and C.M. Greene, "Therapeuticmodulation ofmiRNAfor the treatment of proinflammatory lung diseases" Expert Review of Anti-InfectiveTherapy, vol. 10, no. 3, pp. 359-368, 2012.
22. L. A. O'Neill, F. J. Sheedy, and C. E. McCoy, "MicroRNAs: the fine-tuners of Toll-like receptor signalling" Nature Reviews Immunology, vol. 11, no. 3, pp. 163-175, 2011.
23. S. R. Quinn and L. A.O'Neill, "A trio of microRNAs that control Toll-like receptor signalling" International Immunology, vol. 23, no. 7, pp. 421-425, 2011.
24. I. K. Oglesby, I. M. Bray, S. H. Chotirmall et al., "miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression" The Journal of Immunology, vol. 184, no. 4, pp. 1702-1709, 2010.
25. S. Ganesan, A. T. Comstock, and U. S. Sajjan, "Barrier function of airway tract epithelium" Tissue Barriers, vol. 1, no. 4, Article ID e24997, 2013.
26. C. M. Greene, P. Branagan, and N. G. McElvaney, "Toll-like receptors as therapeutic targets in cystic fibrosis" Expert Opinion onTherapeutic Targets, vol. 12, no. 12, pp. 1481-1495, 2008.
27. D. Hartl, A. Gaggar, E. Bruscia et al., "Innate immunity in cystic fibrosis lung disease" Journal of Cystic Fibrosis, vol. 11, no. 5, pp. 363-382, 2012.
28. A. Mantovani, M. A. Cassatella, C. Costantini, and S. Jaillon, "Neutrophils in the activation and regulation of innate and adaptive immunity" Nature Reviews Immunology, vol. 11, no. 8, pp. 519-531, 2011.
29. C. Taggart, R. J. Coakley, P. Greally, G. Canny, S. J. O'Neill, and N. G. McElvaney, "Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-Alpha and interleukin-8" The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 278, no. 1, pp. L33-L41, 2000.
30. N. E. Alexis, M. S. Muhlebach, D. B. Peden, and T. L. Noah, "Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients" Journal of Cystic Fibrosis, vol. 5, no. 1, pp. 17-25, 2006.
31. D. Hartl, P. Latzin, P. Hordijk et al., "Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease" Nature Medicine, vol. 13, no. 12, pp. 1423-1430, 2007.
32. R. G. Painter, V. G. Valentine, N. A. Lanson Jr. et al., "CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis" Biochemistry, vol. 45, no. 34, pp. 10260-10269, 2006.
33. K. Pohl, E. Hayes, J. Keenanet al., "Aneutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy" Blood, vol. 124, no. 7, pp. 999-1009, 2014.
34. C. Auffray, M. H. Sieweke, and F. Geissmann, "Blood monocytes: development, heterogeneity, and relationship with dendritic cells" Annual Review of Immunology, vol. 27, pp. 669-692, 2009.
35. D. C. Dale, L. Boxer, and W. Conrad Liles, "The phagocytes: neutrophils and monocytes" Blood, vol. 112, no. 4, pp. 935-945, 2008.
36. S. Brennan, P. D. Sly, C. L. Gangell et al., "Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis" European Respiratory Journal, vol. 34, no. 3, pp. 655-661, 2009.
37. R. Legssyer, F. Huaux, J. Lebacq et al., "Azithromycin reduces spontaneous and induced inflammation in ?F508 cystic fibrosis mice" Respiratory Research, vol. 7, article 134, 2006.
38. E. M. Bruscia, P.-X. Zhang, E. Ferreira et al., "Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator?/? mice" American Journal of Respiratory Cell andMolecular Biology, vol. 40, no. 3, pp. 295-304, 2009.
39. M. M. Zaman, A. Gelrud, O. Junaidi et al., "Interleukin 8 secretion from monocytes of subjects heterozygous for the ?F508 cystic fibrosis transmembrane conductance regulator gene mutation is altered" Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 5, pp. 819-824, 2004.
40. E. M. Bruscia, P.-X. Zhang, A. Satoh et al., "Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis" Journal of Immunology, vol. 186, no. 12, pp. 6990-6998, 2011.
41. C. Andersson, M. M. Zaman, A. B. Jones, and S. D. Freedman, "Alterations in immune response and PPAR/LXR regulation in cystic fibrosismacrophages" Journal of Cystic Fibrosis, vol. 7, no. 1, pp. 68-78, 2008.
42. L. V. Deriy, E. A. Gomez, G. Zhang et al., "Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages"The Journal of Biological Chemistry, vol. 284, no. 51, pp. 35926-35938, 2009.
43. A. Di, M. E. Brown, L. V. Deriy et al., "CFTR regulates phagosome acidification inmacrophages and alters bactericidal activity" Nature Cell Biology, vol. 8, no. 9, pp. 933-944, 2006.
44. P. M. Haggie and A. S. Verkman, "Cystic fibrosis transmembrane conductance regulator-independent phagosomal acidification in macrophages" Journal of Biological Chemistry, vol. 282, no. 43, pp. 31422-31428, 2007.
45. R.W. Vandivier, T. R. Richens, S. A. Horstmann et al., "Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences"The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 297, no. 4, pp. L677-L686, 2009.
46. R.W. Vandivier, V. A. Fadok, C. A. Ogden et al., "Impaired clearance of apoptotic cells from cystic fibrosis airways" Chest, vol. 121, no. 3, supplement, p. 89S, 2002.
47. R. W. Vandivier, V. A. Fadok, P. R. Hoffmann et al., "Elastasemediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis" The Journal of Clinical Investigation, vol. 109, no. 5, pp. 661-670, 2002.
48. J. F. Alcorn and J. R. Wright, "Degradation of pulmonary surfactant proteinDby Pseudomonas aeruginosa elastase abrogates innate immune function"The Journal of Biological Chemistry, vol. 279, no. 29, pp. 30871-30879, 2004.
49. N. Guyot, G. Bergsson, M. W. Butler et al., "Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases" Biological Chemistry, vol. 391, no. 6, pp. 705-716, 2010.
50. S. Cosgrove, S. H. Chotirmall, C. M. Greene, and N. G. McElvaney, "Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/toll-like receptor pathway" The Journal of Biological Chemistry, vol. 286, no. 9, pp. 7692-7704, 2011.
51. S.A. Gharib, T. Vaisar, M. L. Aitken, D. R. Park, J.W. Heinecke, and X. Fu, "Mapping the lung proteome in cystic fibrosis" Journal of Proteome Research, vol. 8, no. 6, pp. 3020-3028, 2009.
52. M. W. Konstan, K. A. Hilliard, T. M. Norvell, and M. Berger, "Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation" The American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 2, pp. 448-454, 1994.
53. T. Z. Khan, J. S. Wagener, T. Bost, J. Martinez, F. J. Accurso, and D.W. H. Riches, "Early pulmonary inflammation in infants with cystic fibrosis" American Journal of Respiratory and Critical Care Medicine, vol. 151, no. 4, pp. 1075-1082, 1995.
54. V. Witko-Sarsat, L. Halbwachs-Mecarelli, A. Schuster et al., "Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum" The American Journal of Respiratory Cell and Molecular Biology, vol. 20, no. 4, pp. 729-736, 1999.
55. W. Goldstein and G. Doring, "Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis" American Review of Respiratory Disease, vol. 134, no. 1, pp. 49-56, 1986.
56. S. Weldon, P. McNally, D. F. McAuley et al., "miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production" American Journal of Respiratory and Critical CareMedicine, vol. 190, no. 2, pp. 165-174, 2014.
57. M. A. Mall and C. Schultz, "A new player in the game: epithelial cathepsin S in early cystic fibrosis lung disease" American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 2, pp. 126-127, 2014.
58. E. Fabbri, M. Borgatti, G. Montagner et al., "Expression of microRNA-93 and interleukin-8 during Pseudomonas aeruginosamediated induction of proinflammatory responses" American Journal of Respiratory Cell and Molecular Biology, vol. 50, no. 6, pp. 1144-1155, 2014.
59. M. Dean, A. Rzhetsky, and R. Allikmets, "The human ATP-binding cassette (ABC) transporter superfamily" Genome Research, vol. 11, no. 7, pp. 1156-1166, 2001.
60. B. J. Wainwright, P. J. Scambler, J. Schmidtke et al., "Localization of cystic fibrosis locus to human chromosome 7cen-q22" Nature, vol. 318, no. 6044, pp. 384-385, 1985.
61. A. Caputo, E. Caci, L. Ferrera et al., "TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity" Science, vol. 322, no. 5901, pp. 590-594, 2008.
62. H. C. Chan, Q. X. Shi, C. X. Zhou et al., "Critical role of CFTR in uterine bicarbonate secretion and the fertilizing capacity of sperm" Molecular and Cellular Endocrinology, vol. 250, no. 1-2, pp. 106-113, 2006.
63. I. Kogan, M. Ramjeesingh, C. Li et al., "CFTR directly mediates nucleotide-regulated glutathione flux" The EMBO Journal, vol. 22, no. 9, pp. 1981-1989, 2003.
64. M. J. Stutts, C.M. Canessa, J. C. Olsen et al., "CFTR as a cAMPDependent regulator of sodium channels" Science, vol. 269, no. 5225, pp. 847-850, 1995.
65. M. Mall, B. R. Grubb, J. R. Harkema, W. K. O'Neal, and R. C. Boucher, "Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice" Nature Medicine, vol. 10, no. 5, pp. 487-493, 2004.
66. J. F. Collawn, A. Lazrak, Z. Bebok, and S. Matalon, "The CFTR and ENaC debate: how important is ENaC in CF lung disease?" The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 302, no. 11, pp. L1141-L1146, 2012.
67. A. E. Gillen, N. Gosalia, S.-H. Leir, and A. Harris, "microRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene" Biochemical Journal, vol. 438, no. 1, pp. 25-32, 2011.
68. F. Megiorni, S. Cialfi, C. Dominici, S. Quattrucci, and A. Pizzuti, "Synergistic post-transcriptional regulation of the Cystic fibrosis transmembrane conductance regulator (CFTR) by miR-101 and miR-494 specific binding" PLoS ONE, vol. 6, no. 10, Article ID e26601, 2011.
69. S. Ramachandran, P. H. Karp, P. Jiang et al., "A microRNA network regulates expression and biosynthesis of wild-type and ?F508 mutant cystic fibrosis transmembrane conductance regulator" Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 33, pp. 13362-13367, 2012.
70. F. Hassan, G. J. Nuovo, M. Crawford et al., "MiR-101 andmiR-144 regulate the expression of the CFTR chloride channel in the lung" PLoS ONE, vol. 7, no. 11, Article ID e50837, 2012.
71. I. K. Oglesby, S. H. Chotirmall, N. G. McElvaney, and C. M. Greene, "Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145,-223, and-494 is altered in DeltaF508 cystic fibrosis airway epithelium" Journal of Immunology, vol. 190, no. 7, pp. 3354-3362, 2013.
72. F. Amato, M. Seia, S. Giordano et al., "Genemutation inMicro-RNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis?" PLoS ONE, vol. 8, no. 3, Article ID e60448, 2013.
73. S. Ramachandran, P. H. Karp, S. R. Osterhaus et al., "Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by MicroRNAs" American Journal of Respiratory Cell andMolecular Biology, vol. 49, no. 4, pp. 544-551, 2013.
74. F. Amato, R. Tomaiuolo, F. Nici et al., "Exploitation of a very small peptide nucleic acid as a new inhibitor of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression" BioMed Research International, vol. 2014, Article ID 610718, 10 pages, 2014.
75. V. Viart, A. Bergougnoux, J. Bonini et al., "Transcription factors and miRNAs that regulate fetal to adult CFTR expression change are new targets for cystic fibrosis" European Respiratory Journal, vol. 45, no. 1, pp. 116-128, 2015.
76. C. M. Greene and D. Hartl, "Developmental control of CFTR: frombioinformatics to novel therapeutic approaches" European Respiratory Journal, vol. 45, no. 1, pp. 18-20, 2015.
77. T. Hassan, T. P. Carroll, P. G. Buckley et al., "MiR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and alpha1-Antitrypsin deficiency" The American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 3, pp. 263-273, 2014.
78. W.-G. Zhang, L. Chen, Q. Dong et al., "mmu-miR-702 functions as an anti-Apoptotic mirtron by mediating ATF6 inhibition in mice" Gene, vol. 531, no. 2, pp. 235-242, 2013.
79. F. Yang, L. Zhang, F. Wang et al., "Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma 1, 2" Neoplasia, vol. 13, no. 7, pp. 590-600, 2011.
80. A. E. Byrd, I. V. Aragon, and J. W. Brewer, "MicroRNA-30c-2? limits expression of proadaptive factor XBP1 in the unfolded protein response" Journal of Cell Biology, vol. 196, no. 6, pp. 689-698, 2012.
81. I. K. Oglesby, R. Agrawal, M. A. Mall, N. G. McElvaney, and C. M. Greene, "miRNA-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression ofATF6"Molecular and Cellular Pediatrics, vol. 1, 2015.
82. K. Haze, H. Yoshida, H. Yanagi, T. Yura, and K. Mori, "Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulumstress"Molecular Biology of the Cell, vol. 10, no. 11, pp. 3787-3799, 1999.
83. P. J. McKiernan, O. Cunningham, C. M. Greene, and S. A. Cryan, "Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology" International Journal of Nanomedicine, vol. 8, pp. 3907-3915, 2013.